Literature DB >> 25963172

Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations.

A C Sawant1, H Calkins.   

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a rare cardiomyopathy associated with life-threatening arrhythmias and an increased risk of sudden cardiac death. In addition to mutations in desmosomal genes, environmental factors such as exercise and sport have been implicated in the pathogenesis of the disease. Recent studies have shown that exercise may be associated with adverse outcomes in patients with ARVD/C. On the basis of current evidence, patients with ARVD/C are recommended to limit exercise irrespective of their mutation status. Some studies have suggested the presence of an entirely acquired form of the disease caused by exercise, which has been dubbed "exercise-induced ARVD/C."

Entities:  

Mesh:

Year:  2015        PMID: 25963172     DOI: 10.1007/s00059-015-4223-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  64 in total

1.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

Authors:  Aditya Bhonsale; Cynthia A James; Crystal Tichnell; Brittney Murray; Dmitri Gagarin; Binu Philips; Darshan Dalal; Ryan Tedford; Stuart D Russell; Theodore Abraham; Harikrishna Tandri; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells.

Authors:  Eva M Oxford; Hassan Musa; Karen Maass; Wanda Coombs; Steven M Taffet; Mario Delmar
Journal:  Circ Res       Date:  2007-08-02       Impact factor: 17.367

3.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.

Authors:  Frank I Marcus; Wojciech Zareba; Hugh Calkins; Jeffrey A Towbin; Cristina Basso; David A Bluemke; N A Mark Estes; Michael H Picard; Danita Sanborn; Gaetano Thiene; Thomas Wichter; David Cannom; David J Wilber; Melvin Scheinman; Henry Duff; James Daubert; Mario Talajic; Andrew Krahn; Michael Sweeney; Hasan Garan; Scott Sakaguchi; Bruce B Lerman; Charles Kerr; Jack Kron; Jonathan S Steinberg; Duane Sherrill; Kathleen Gear; Mary Brown; Patricia Severski; Slava Polonsky; Scott McNitt
Journal:  Heart Rhythm       Date:  2009-03-11       Impact factor: 6.343

4.  Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin.

Authors:  A La Gerche; C Robberecht; C Kuiperi; D Nuyens; R Willems; T de Ravel; G Matthijs; H Heidbüchel
Journal:  Heart       Date:  2010-06-04       Impact factor: 5.994

5.  Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy.

Authors:  Giovanni Quarta; Petros Syrris; Michael Ashworth; Sharon Jenkins; Krisztina Zuborne Alapi; John Morgan; Alison Muir; Antonios Pantazis; William J McKenna; Perry M Elliott
Journal:  Eur Heart J       Date:  2011-12-23       Impact factor: 29.983

6.  Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Binu Philips; Anneline S J M te Riele; Abhishek Sawant; Vishnupriya Kareddy; Cynthia A James; Brittney Murray; Crystal Tichnell; Bina Kassamali; Saman Nazarian; Daniel P Judge; Hugh Calkins; Harikrishna Tandri
Journal:  Heart Rhythm       Date:  2014-12-18       Impact factor: 6.343

7.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.

Authors:  Aditya Bhonsale; Judith A Groeneweg; Cynthia A James; Dennis Dooijes; Crystal Tichnell; Jan D H Jongbloed; Brittney Murray; Anneline S J M te Riele; Maarten P van den Berg; Hennie Bikker; Douwe E Atsma; Natasja M de Groot; Arjan C Houweling; Jeroen F van der Heijden; Stuart D Russell; Pieter A Doevendans; Toon A van Veen; Harikrishna Tandri; Arthur A Wilde; Daniel P Judge; J Peter van Tintelen; Hugh Calkins; Richard N Hauer
Journal:  Eur Heart J       Date:  2015-01-23       Impact factor: 29.983

8.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear.

Authors:  Binu Philips; Srinivasa Madhavan; Cynthia A James; Anneline S J M te Riele; Brittney Murray; Crystal Tichnell; Aditya Bhonsale; Saman Nazarian; Daniel P Judge; Hugh Calkins; Harikrishna Tandri; Alan Cheng
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-03-01

9.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Brenda Gerull; Arnd Heuser; Thomas Wichter; Matthias Paul; Craig T Basson; Deborah A McDermott; Bruce B Lerman; Steve M Markowitz; Patrick T Ellinor; Calum A MacRae; Stefan Peters; Katja S Grossmann; Jörg Drenckhahn; Beate Michely; Sabine Sasse-Klaassen; Walter Birchmeier; Rainer Dietz; Günter Breithardt; Eric Schulze-Bahr; Ludwig Thierfelder
Journal:  Nat Genet       Date:  2004-10-17       Impact factor: 38.330

Review 10.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Authors:  Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

View more
  3 in total

Review 1.  [Exercise training in the therapy of heart diseases: Current evidence and future options].

Authors:  S Schwarz; A Boscheri; J Christle; A Duvinage; K Esefeld; H Fricke; N Pitsch; A Pressler; M Weichenberger; M Halle
Journal:  Herz       Date:  2016-03       Impact factor: 1.443

Review 2.  Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Authors:  Perry M Elliott; Aris Anastasakis; Angeliki Asimaki; Cristina Basso; Barbara Bauce; Matthew A Brooke; Hugh Calkins; Domenico Corrado; Firat Duru; Kathleen J Green; Daniel P Judge; David Kelsell; Pier D Lambiase; William J McKenna; Kalliopi Pilichou; Alexandros Protonotarios; Jeffrey E Saffitz; Petros Syrris; Hari Tandri; Anneline Te Riele; Gaetano Thiene; Adalena Tsatsopoulou; J Peter van Tintelen
Journal:  Eur J Heart Fail       Date:  2019-06-18       Impact factor: 15.534

Review 3.  The potential role of endogenous bacteriophages in controlling invading pathogens.

Authors:  Andrzej Górski; Beata Weber-Dabrowska
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.